252
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Targeting Olokizumab-Interleukin 6 interaction interface to discover novel IL-6 inhibitors

, , , , , ORCID Icon, ORCID Icon, & ORCID Icon show all
Pages 14003-14015 | Received 05 Oct 2022, Accepted 29 Jan 2023, Published online: 30 Mar 2023

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.